NasdaqGS - Nasdaq Real Time Price ? USD Natera, Inc. (NTRA) Follow Compare 167.26 -2.10 (-1.24%) At close: 4:00 PM EST 167.26 0.00 (0.00%) After hours: 4:02 PM EST All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Natera Announces Publication of over 100 Peer-Reviewed Papers on SignateraTM AUSTIN, Texas, November 21, 2024--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that it has surpassed a key milestone with over 100 peer-reviewed publications on its personalized and tumor-informed molecular residual disease (MRD) test, Signatera. Business Wire ? 22 hours ago NTRA -1.24% Natera, Inc. (NASDAQ:NTRA) Just Reported And Analysts Have Been Lifting Their Price Targets Natera, Inc. ( NASDAQ:NTRA ) just released its quarterly report and things are looking bullish. Revenue crushed... Simply Wall St. ? 7 days ago NTRA -1.24% Stanley Druckenmiller's Strategic Emphasis on Natera Inc in Q3 2024 Insight into Druckenmiller's Latest 13F Filings and Portfolio Adjustments GuruFocus.com ? 7 days ago NTRA -1.24% AVGO Natera Third Quarter 2024 Earnings: Beats Expectations Natera ( NASDAQ:NTRA ) Third Quarter 2024 Results Key Financial Results Revenue: US$439.8m (up 64% from 3Q 2023). Net... Simply Wall St. ? 8 days ago NTRA -1.24% Natera Stock Explodes 20% After Record-Breaking Q3--Is This Biotech Giant Just Getting Started? Massive revenue growth, surging margins, and groundbreaking cancer breakthroughs--Natera's unstoppable rise is turning heads GuruFocus.com ? 9 days ago NTRA -1.24% Natera Inc (NTRA) Q3 2024 Earnings Call Highlights: Record Revenue and Raised Guidance Amid ... Natera Inc (NTRA) reports a 64% revenue increase and raises annual guidance, driven by robust oncology test performance and improved gross margins. GuruFocus.com ? 9 days ago NTRA -1.24% Decoding Natera Inc (NTRA): A Strategic SWOT Insight Comprehensive Analysis Post Q3 2024 Financials GuruFocus.com ? 9 days ago NTRA -1.24% Natera (NTRA) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates The headline numbers for Natera (NTRA) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals. Zacks ? 9 days ago NTRA -1.24% Natera (NTRA) Reports Q3 Loss, Tops Revenue Estimates Natera (NTRA) delivered earnings and revenue surprises of 54.39% and 21.76%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock? Zacks ? 9 days ago NTRA -1.24% Natera: Q3 Earnings Snapshot AUSTIN, Texas (AP) — Natera Inc. NTRA) on Tuesday reported a loss of $31.6 million in its third quarter. The Austin, Texas-based company said it had a loss of 26 cents per share. Associated Press Finance ? 9 days ago NTRA -1.24% Natera Reports Third Quarter 2024 Financial Results AUSTIN, Texas, November 12, 2024--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today reported its financial results for the third quarter ended September 30, 2024. Business Wire ? 10 days ago NTRA -1.24% Natera Announces Completion of Signatera? Analysis from the CALGB (Alliance)/SWOG 80702 Randomized, Phase III Clinical Trial in Colorectal Cancer AUSTIN, Texas, November 12, 2024--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced the completion of a study using Signatera from the CALGB (Alliance)/SWOG 80702 randomized, phase III clinical trial. CALGB (Alliance)/SWOG 80702 evaluated the benefit of adding celecoxib to FOLFOX in postoperative treatment of stage III colorectal cancer (CRC) in a biomarker unselected population. Business Wire ? 10 days ago NTRA -1.24% Natera to Participate in Upcoming Investor Conferences AUSTIN, Texas, November 08, 2024--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that members of its leadership team will present at the following investor conferences in November and December. Business Wire ? 14 days ago NTRA -1.24% Natera to Report its Third Quarter 2024 Results on November 12, 2024 AUSTIN, Texas, November 01, 2024--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that it will release results for its third quarter ended Sept. 30, 2024, after the market closes on Nov. 12, 2024. Natera will host a conference call and webcast shortly thereafter at 1:30 p.m. PT (4:30 p.m. ET). Business Wire ? 21 days ago NTRA -1.24% Exploring Three High Growth Tech Stocks in the United States Over the last 7 days, the United States market has remained flat, yet it has risen by an impressive 39% over the past 12 months, with earnings forecasted to grow by 15% annually. In this context of robust growth and stability, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation potential and adaptability within this dynamic sector. Simply Wall St. ? 23 days ago PTC ZETA NTRA -1.24% Loss-Making Natera, Inc. (NASDAQ:NTRA) Expected To Breakeven In The Medium-Term Natera, Inc. ( NASDAQ:NTRA ) is possibly approaching a major achievement in its business, so we would like to shine... Simply Wall St. ? 23 days ago NTRA -1.24% All You Need to Know About Natera (NTRA) Rating Upgrade to Strong Buy Natera (NTRA) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. Zacks ? 30 days ago NTRA -1.24% Natera to Present New Renasight Data at ASN Kidney Week 2024 AUSTIN, Texas, October 22, 2024--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) and genetic testing, today announced that the company will present new data on its 385-gene kidney genetic test, Renasight?, at the annual meeting of the American Society of Nephrology (ASN) Kidney Week 2024. The meeting will take place in San Diego from Oct. 23-27. Business Wire ? last month NTRA -1.24% Natera Inc. (NTRA): Hedge Funds Are Bullish On This NASDAQ Stock Right Now We recently compiled a list of the 10 Best Performing NASDAQ Stocks in 2024. In this article, we are going to take a look at where Natera Inc. (NASDAQ:NTRA) stands against the other great performing NASDAQ stocks. Market Expectations for the Year-End Fed’s recent cut has resulted in significant outperformance in the tech sector, signaling a […] Insider Monkey ? last month NTRA -1.24% ^GSPC High Growth Tech Stocks To Watch In September 2024 In the last week, the market has stayed flat, but it is up 32% over the past year with earnings expected to grow by 15% per annum over the next few years. In this environment, identifying high growth tech stocks that can capitalize on these favorable conditions becomes crucial for investors looking to maximize their returns. Simply Wall St. ? last month CGNX NTRA -1.24% CERT Performance Overview Trailing total returns as of 11/22/2024, which may include dividends or other distributions. Benchmark is S&P 500 Return NTRA S&P 500 YTD +167.02% +25.15% 1-Year +210.03% +31.54% 3-Year +62.11% +27.06%
